Stromal Vascular Fraction for Osteoarthritis of the Knee Regenerative Engineering
Tóm tắt
The knee joint is prone to osteoarthritis (OA) due to its anatomical position, and several reports have implicated the imbalance between catabolic and anabolic processes within the joint as the main culprit, thus leading to investigations towards attenuation of these inflammatory signals for OA treatment. In this review, we have explored clinical evidence supporting the use of stromal vascular fraction (SVF), known for its anti-inflammatory characteristics for the treatment of OA. Searches were made on PubMed, PMC, and Google Scholar with the keywords “adipose fraction knee regeneration, and stromal vascular fraction knee regeneration, and limiting searches within 2017–2020. Frequently found interventions include cultured adipose-derived stem cells (ADSCs), SVF, and the micronized/microfragmented adipose tissue-stromal vascular fraction (MAT-SVF). Clinical data reported that joints treated with SVF provided a better quality of life to patients. Currently, MAT-SVF obtained and administered at the point of care is approved by the Food and Drug Administration (FDA), but more studies including manufacturing validation, safety, and proof of pharmacological activity are needed for SVF. The mechanism of action of MAT-SVF is also not fully understood. However, the current hypothesis indicates a direct adherence and integration with the degenerative host tissue, and/or trophic effects resulting from the secretome of constituent cells. Our review of the literature on stromal vascular fraction and related therapy use has found evidence of efficacy in results. More research and clinical patient follow-up are needed to determine the proper place of these therapies in the treatment of osteoarthritis of the knee. Reports have implicated the increased inflammatory proteins within the joints as the main cause of osteoarthritis (OA). This has attracted interest towards addressing these inflammatory proteins as a way of treatment for OA. The concentrated cell-packed portion of the adipose product stromal vascular fraction (SVF) from liposuction or other methods possesses anti-inflammatory effects and has been acclaimed to heal OA. Thus, we searched for clinical evidence supporting their use, for OA treatment through examining the literature. Data from various hospitals support that joints treated with SVF provided a better quality of life to patients. Currently, there is at least one version of these products that are obtained and given back to patients during a single clinic visit, approved by the FDA.
Tài liệu tham khảo
Jones IA, et al. A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol. BMC Musculoskelet Disord. 2018;19(1):383. https://doi.org/10.1186/s12891-018-2300-7.
Hudetz D, et al. Early results of intra-articular micro-fragmented lipoaspirate treatment in patients with late stages knee osteoarthritis: a prospective study. Croat Med J. 2019;60(3):227–36.
Garza JR, et al. Clinical efficacy of intra-articular mesenchymal stromal cells for the treatment of knee osteoarthritis: a double-blinded prospective randomized controlled clinical trial. Am J Sports Med. 2020;48(3):588–98.
Tran TDX, et al. Time- and Kellgren–lawrence grade-dependent changes in intra-articularly transplanted stromal vascular fraction in osteoarthritic patients. Cells. 2019;8(4):308. https://doi.org/10.3390/cells8040308.
Ude CC, et al. Application of stem cells in tissue engineering for defense medicine. Mil Med Res. 2018;5(1):7.
Mehranfar S, et al. The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials. Artific Cells Nanomed Biotechnol. 2019;47(1):882–90.
Russo A, et al. Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. J Exp Orthop. 2017;4(1):33.
Onoi Y, et al. Second-look arthroscopic findings of cartilage and meniscus repair after injection of adipose-derived regenerative cells in knee osteoarthrits: Report of two cases. Regen Ther. 2019;11:212–6.
Hong Z, et al. Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop. 2019;43(5):1123–34.
Mark B, et al. Prospective study of autologous adipose derived stromal vascular fraction containing stem cells for the treatment of knee osteoarthritis. Int J Stem Cell Res Ther. 2019;6(1). https://doi.org/10.23937/2469-570X/1410064
Michalek J, et al. Stromal vascular fraction cell therapy for osteoarthritis in elderly: multicenter case-control study. J Clin Orthop Trauma. 2019;10(1):76–80.
Kumar A, Kadamb AG, Kadamb K. Understanding the role of platelet rich plasma bone marrow concentrate micro fragmented adipose tissue stromal vascular fraction and stem cell in osteoarthritis of the knee - its time to wake up! EC Orthop. 2019;10(9):804–12.
Lv X, et al. Comparative efficacy of autologous stromal vascular fraction and autologous adipose-derived mesenchymal stem cells combined with hyaluronic acid for the treatment of sheep osteoarthritis. Cell Transplant. 2018;27(7):1111–25.
Senesi L, et al. Mechanical and enzymatic procedures to isolate the stromal vascular fraction from adipose tissue: preliminary results. Front Cell Dev Biol. 2019;7:88.
Roato I, et al. Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations. Int Orthop. 2019;43(1):15–23.
Dykstra JA, et al. Concise review: fat and furious: harnessing the full potential of adipose-derived stromal vascular fraction. Stem Cells Transl Med. 2017;6(4):1096–108.
Russo A, et al. Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up. J Exp Orthop. 2018;5(1):52.
Parsons AM, et al. Regenerative potential and inflammation-induced secretion profile of human adipose-derived stromal vascular cells are influenced by donor variability and prior breast cancer diagnosis. Stem Cell Rev Rep. 2018;14(4):546–57.
Yokota N, et al. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med. 2019;47(11):2577–83.
Pak J, et al. Cartilage regeneration in humans with adipose tissue-derived stem cells and adipose stromal vascular fraction cells: updated status. Int J Mol Sci. 2018;19(7):2146. https://doi.org/10.3390/ijms19072146.
Kemilew J, et al. The use of allogenic stromal vascular fraction (SVF) cells in degenerative joint disease of the spine in dogs. In Vivo. 2019;33(4):1109–17.
Desando G, et al. Regenerative features of adipose tissue for osteoarthritis treatment in a rabbit model: enzymatic digestion versus mechanical disruption. Int J Mol Sci. 2019;20(11):2636. https://doi.org/10.3390/ijms20112636.
Shiv Shah TO, Bhattacharjee M, Laurencin CT. Minimally invasive cellular therapies for osteoarthritis treatment. Regen Eng Transl Med. 2021;7:76–90.
Nurnberger S, et al. Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy: the microtissue-stromal vascular fraction. Eur Cell Mater. 2019;37:113–33.
Shimozono Y, et al. Adipose-based therapies for knee pain-fat or fiction. J Knee Surg. 2019;32(1):55–64.
Daneshmandi L, et al. Emergence of the stem cell secretome in regenerative engineering. Trends Biotechnol. 2020;38(12):1373–84.
Chang J, Liao Z, Lu M, Meng T, Han W, Ding C. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis Cartilage. 2018;26(7):864–71.
Polancec Z, et al. Immunophenotyping of a stromal vascular fraction from microfragmented lipoaspirate used in osteoarthritis cartilage treatment and its lipoaspirate counterpart. Genes. 2019;10(6):474. https://doi.org/10.3390/genes10060474.
Bisicchia S, et al. Micro-fragmented stromal-vascular fraction plus microfractures provides better clinical results than microfractures alone in symptomatic focal chondral lesions of the knee. Knee Surg Sports Traumatol Arthrosc. 2019;28(6):1876–84. https://doi.org/10.1007/s00167-019-05621-0.
Ashammakhi N, et al. Minimally invasive and regenerative therapeutics. Adv Mater. 2019;31(1):e1804041.
Salikhov RZ, et al. The Stromal vascular fraction from fat tissue in the treatment of osteochondral knee defect: case report. Front Med. 2018;5:154.
Michalek J, et al. Stromal vascular fraction cells of adipose and connective tissue in people with osteoarthritis: a case control prospective multi-centric non-randomized study. Glob Surg. 2017;3(3):1–9. https://doi.org/10.15761/GOS.1000163.
Kilinc MO, et al. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018;7:5. https://doi.org/10.1186/s40169-018-0183-8.
Fotouhi A, et al. Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis. Biomed Pharmacother. 2018;104:652–60.
Rodriguez J, et al. Evaluation of three devices for the isolation of the stromal vascular fraction from adipose tissue and for ASC culture: a comparative study. Stem Cells Int. 2017;2017:9289213.
Cletus UC, Miskon A, Idrus RHj. Strides towards the realization of cure for cartilage defects and osteoarthritis: the limitation and regulatory challenges. Sains Malaysiana. 2018;47(11):2757–67.
FDA-Canada. Health Canada Policy Position Paper – Autologous Cell Therapy Products - Canada.ca. 2020. https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications. Accessed 07-10-20.
Meirelles Lda S, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5–6):419–27.
Wong SP, et al. Pericytes, mesenchymal stem cells and their contributions to tissue repair. Pharmacol Ther. 2015;151:107–20.
Abdel-Fattah WI, et al. Synthesis, characterization of chitosans and fabrication of sintered chitosan microsphere matrices for bone tissue engineering. Acta Biomater. 2007;3(4):503–14.
Barajaa MA, Nair LS, Laurencin CT. Bioinspired scaffold designs for regenerating musculoskeletal tissue interfaces. Regen Eng Transl Med. 2020;6(4):451–83.
Laurencin CT, McClinton A. Regenerative cell-based therapies: cutting edge, bleeding edge, and off the edge. Regen Eng Transl Med. 2020;6:78–89.
Laurencin CT, Nair LS. Nanotechnology and tissue engineering - the scaffold. 1st ed. CRC Press; 2008. p. 384.
Kuyinu EL, et al. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res. 2016;11:19.
Laurencin CT, Khan Y. Regenerative engineering. Sci Transl Med. 2012;4(160):160ed9-160ed9.
Laurencin CT, Khan Y. Regenerative engineering. In: Laurencin CT, Khan Y, editors. Google books. CRC Press/Taylor & Francis Group; 2013.
Laurencin CT, Nair LS. Regenerative engineering: approaches to limb regeneration and other grand challenges. Regen Eng Transl Med. 2015;1(1):1–3.
Botchwey EA, Pollack SR, El-Amin S, Levine EM, Tuan RS, Laurencin CT. Human osteoblast-like cells in threedimensional culture with fluid flow. Biorheology. 2003;40(1–3):299–306.
Escobar Ivirico JL, et al. Regenerative engineering for knee osteoarthritis treatment: biomaterials and cell-based technologies. Engineering. 2017;3(1):16–27.
Narayanan G, Bhattacharjee M, Nair LS, Laurencin CT. Musculoskeletal tissue regeneration: the role of the stem cells. Regen Eng Transl Med. 2017;3(3):133–65. https://doi.org/10.1007/s40883-017-0036-9.
Kasir R, Vernekar VN, Laurencin CT. Regenerative engineering of cartilage using adipose-derived stem cells. Regen Eng Transl Med. 2015;1(1):42–9.
Kumbar SG, et al. Polymeric nanofibers as novel carriers for the delivery of therapeutic molecules. J Nanosci Nanotechnol. 2006;6(9–10):2591–607.
Lv Q, Nair L, Laurencin CT. Fabrication, characterization, and in vitro evaluation of poly(lactic acid glycolic acid)/nano-hydroxyapatite composite microsphere-based scaffolds for bone tissue engineering in rotating bioreactors. J Biomed Mater Res A. 2009;91(3):679–91.
Deng M, Nair LS, Nukavarapu SP, Kumbar SG, Jiang T, Krogman NR, Singh A, Allcock HR, Laurencin T. Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Biomaterials. 2008;29(3):337–49. https://doi.org/10.1016/j.biomaterials.2007.09.029.
Nelson C, Khan Y, Laurencin CT. Nanofiber/microsphere hybrid matrices in vivo for bone regenerative engineering: a preliminary report. Regen Eng Transl Med. 2018;4(3):133–41.
Ogueri KS, et al. Biodegradable polyphosphazene-based blends for regenerative engineering. Regen Eng Transl Med. 2017;3(1):15–31.
Ogueri KS, et al. Polymeric biomaterials for scaffold-based bone regenerative engineering. Regen Eng Transl Med. 2019;5(2):128–54.
Otsuka T, et al. Identification of heparan-sulfate rich cells in the loose connective tissues of the axolotl (Ambystoma mexicanum) with the potential to mediate growth factor signaling during regeneration. Regen Eng Transl Med. 2020;6(1):7–17.
Beachy SH, Nair L, Laurencin C, Tsokas KA, Lundberg MS. Sources of variability in clinical translation of regenerative engineering products: insights from the national academies forum on regenerative medicine. Regen Eng Transl Med. 2020;6(1):1–6. https://doi.org/10.1007/s40883-020-00151-5.
Ifegwu OC, Awale G, Kan HM, Rajpura K, O’Neill E, Kuo C-L, Lo KW-H. Bone regenerative engineering using a protein kinase a-specific cyclic AMP Analogue Administered for Short Term. Regen Eng Transl Med. 2018;4(4):206–15. https://doi.org/10.1007/s40883-018-0063-1.
Mengsteab PY, Freeman J, Barajaa MA, Nair LS, Laurencin CT. Ligament regenerative engineering: braiding scalable and tunable bioengineered ligaments using a benchtop braiding machine. Regen Eng Transl Med. 2020. https://doi.org/10.1007/s40883-020-00178-8.
Ibim SE, Uhrich KE, Attawia M, Shastri VR, El-Amin SF, Bronson R, Langer R, Laurencin CT. Preliminary in vivo report on the osteocompatibility of poly (anhydride-co-imides) evaluated in a tibial model. J Biomed Mater Res. 1998;43(4):374–9.
Sethuraman S, et al. Mechanical properties and osteocompatibility of novel biodegradable alanine based polyphosphazenes: Side group effects. Acta Biomater. 2010;6(6):1931–7.
Tang X, et al. Biomimetic electroconductive nanofibrous matrices for skeletal muscle regenerative engineering. Regen Eng Transl Med. 2020;6(2):228–37.
Jiang T, Deng M, James R, Nair LS, Laurencin CT. Micro- and nanofabrication of chitosan structures for regenerative engineering. Acta Biomater. 2014;10(4):1632–45. https://doi.org/10.1016/j.actbio.2013.07.003.
Wang J, et al. Spiral-structured, nanofibrous, 3D scaffolds for bone tissue engineering. J Biomed Mater Res A. 2010;93(2):753–62.
Bhattacharjee M, et al. Preparation and characterization of amnion hydrogel and its synergistic effect with adipose derived stem cells towards IL1beta activated chondrocytes. Sci Rep. 2020;10(1):18751.